NEW
YORK, March 22, 2023 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Amgen
Inc..
Shareholders who purchased shares of AMGN during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/amgen-inc-loss-submission-form/?id=37494&from=4
CLASS PERIOD: This lawsuit is on behalf of all persons
who purchased or otherwise acquired Amgen common stock between
July 29, 2020 and April 27, 2022, inclusive.
ALLEGATIONS: The complaint alleges that during the class
period, Defendants issued materially false and/or misleading
statements and/or failed to disclose that: (a) the U.S. government
claimed Amgen owed more than $3
billion in back taxes for tax years 2010, 2011, and 2012;
(b) the U.S. government claimed Amgen owed more than $5 billion in back taxes for tax years 2013,
2014, and 2015; (c) the U.S. government would likely claim Amgen
owed materially more to the U.S. government than investors had been
led to believe for subsequent tax years for which the Company had
used the same profit allocation treatment between its U.S. and
Puerto Rico operations; (d) Amgen had not taken sufficient accruals
to account for its outstanding tax liabilities; (e) Amgen had
failed to comply with Accounting Standards Codification Topic 450
and other rules and regulations regarding the preparation of its
periodic filings with the U.S. Securities and Exchange Commission;
and (f) Amgen's refusal to pay taxes claimed by the U.S. government
exposed the Company to a substantial risk of severe financial
penalties imposed by the Internal Revenue Service.
DEADLINE: May 12, 2023
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/amgen-inc-loss-submission-form/?id=37494&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of AMGN during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is May 12, 2023. There is no cost or
obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law Firm is
committed to ensuring that companies adhere to responsible business
practices and engage in good corporate citizenship. The firm seeks
recovery on behalf of investors who incurred losses when false
and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-amgen-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-may-12-2023--nasdaq-amgn-301778219.html
SOURCE The Gross Law Firm